Legacy Education (LGCY) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
29 Nov, 2025Company overview and business model
Operates accredited post-secondary institutions in California focused on healthcare, veterinary, medical IT, and business management programs.
Schools include High Desert Medical College, Central Coast College, and Integrity College of Health, serving 2,187 students as of June 30, 2024.
Programs are career-focused, with strong ties to local employers and high job placement rates.
Target demographic is early to mid-20s seeking economic advancement through in-demand skills.
Growth strategy includes new programs, online offerings, branch campuses, and acquisitions beyond California.
Financial performance and metrics
Revenue for fiscal year ended June 30, 2024 estimated at $45.7–$46.5 million, up from $35.5 million in 2023.
Operating income for 2024 expected at $5.4–$6.3 million, compared to $3.6 million in 2023.
Net income for nine months ended March 31, 2024 was $4.2 million, up 121.9% from prior year period.
Cash and cash equivalents as of March 31, 2024 were $11.4 million; pro forma after IPO, $21.7 million.
Composite score for financial responsibility was 3.0 for 2023, well above regulatory minimum.
Use of proceeds and capital allocation
Net proceeds of ~$10.28 million (or $11.95 million if over-allotment exercised) expected, assuming $6.00/share IPO price.
Proceeds to be used for facility investments, new program development, working capital, and potential acquisitions.
No current commitments for acquisitions; proceeds may be allocated as opportunities arise.
Latest events from Legacy Education
- Q2 revenue up 40.7% and net income up 46%, fueled by enrollment and program expansion.LGCY
Q2 202612 Feb 2026 - Achieved 40% revenue growth and 38% enrollment increase, driven by healthcare-focused programs and acquisitions.LGCY
Investor presentation12 Feb 2026 - Revenue up 35%, net income doubled, and expansion fueled by IPO and $8M acquisition.LGCY
Q1 202514 Jan 2026 - Q2 FY2025 revenue up 29.2% with record enrollment and expanded healthcare offerings.LGCY
Q2 202516 Dec 2025 - Virtual meeting to elect six directors, ratify auditor, and review governance and compensation.LGCY
Proxy Filing2 Dec 2025 - Annual proxy details voting items and confirms standard shareholder rights.LGCY
Proxy Filing2 Dec 2025 - IPO targets $10.28M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025 - IPO seeks $10.28M to fund growth, with strong financials but high regulatory exposure.LGCY
Registration Filing29 Nov 2025 - Strong growth in revenue and enrollment, with IPO funding expansion amid regulatory risks.LGCY
Registration Filing29 Nov 2025